Research programme: rotavirus inhibitors - ShireAlternative Names: VP-1147
Latest Information Update: 22 Dec 2016
At a glance
- Originator ViroPharma
- Class Small molecules
- Mechanism of Action Virus replication inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Rotavirus infections
Most Recent Events
- 01 Jun 2004 Preclinical trials in Rotavirus infections in USA (unspecified route)